Nature Reviews Drug Discovery

Nature Portfolio

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Nature Reviews Drug Discovery is a journal published by Nature Portfolio in United States. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Nature Portfolio
ISSN
1474-1776 · 1474-1784
Country
United States
Access
Not open access / not declared
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2002-01-01
  • PUBMED · 2011-06-24
Indexing
MEDLINE · PUBMED
APC
—
Declared review time (DOAJ)
—
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

6852

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

474

i10-index

2359

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-09-21
CLOCKSSPortico
Norwegian register (HK-dir)— 2027
Level 2 — top tier (~20% of the field's channels)
Open references deposited at Crossref
61%
ORCID iDs in current deposits
17%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Alternate titles
Nat Rev Drug DiscovDrug discovery
Source type
journal
NLM unique ID (PubMed)
101124171
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Science, Research, and Medicine
  • Science, Research, and Medicine
  • Biotechnology and Related Fields
  • Biotechnology and Related Fields
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Pharmaceutical Economics and Policy
  • Pharmaceutical Economics and Policy
Show all subjects (50)
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • Biomedical Ethics and Regulation
  • Biomedical Ethics and Regulation
  • Biosimilars and Bioanalytical Methods
  • Biosimilars and Bioanalytical Methods
  • CAR-T cell therapy research
  • CAR-T cell therapy research
  • Receptor Mechanisms and Signaling
  • Receptor Mechanisms and Signaling
  • CRISPR and Genetic Engineering
  • CRISPR and Genetic Engineering
  • RNA Interference and Gene Delivery
  • RNA Interference and Gene Delivery
  • Protein Degradation and Inhibitors
  • Protein Degradation and Inhibitors
  • Ubiquitin and proteasome pathways
  • Ubiquitin and proteasome pathways
  • Pharmacogenetics and Drug Metabolism
  • Pharmacogenetics and Drug Metabolism
  • Health and Medical Research Impacts
  • Health and Medical Research Impacts
  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • Pharmaceutical studies and practices
  • Pharmaceutical studies and practices
  • Virus-based gene therapy research
  • Virus-based gene therapy research
  • Click Chemistry and Applications
  • Click Chemistry and Applications
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Histone Deacetylase Inhibitors Research
  • Histone Deacetylase Inhibitors Research
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Alzheimer's disease research and treatments
  • Alzheimer's disease research and treatments

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: